This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Feb. 11, 2014 /PRNewswire/ -- Harwood Feffer LLP (
www.hfesq.com) is investigating potential claims against the board of directors of Cadence Pharmaceuticals, Inc. ("Cadence" or the "Company") (NASDAQ: CADX) concerning the proposed acquisition of the Company by
Mallinckrodt plc ("